23min chapter

The Trip Report cover image

Ep #30 Nick Gillespie: Reflection on the FDA’s Rejection of MDMA Assisted Therapy

The Trip Report

CHAPTER

Navigating FDA Challenges for MDMA Therapy

This chapter explores the difficulties faced in securing FDA approval for MDMA-assisted therapy, emphasizing the complexities of drug regulation and the challenges of studying psychedelics. It contrasts the experiences of grassroots organizations with those of established pharmaceutical companies, revealing biases and systemic hurdles in the approval process. Additionally, the chapter reflects on the evolving societal attitudes toward psychedelics and the urgent need for reform in drug policy.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode